Hospital gives first tomosynthesis mammograms in region this week

December 7, 2011 in Cancer

There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer battle to the next level with the installation of the most advanced imaging technology available, called digital breast tomosynthesis.

Women & Infants is the first and only facility in southeastern New England to offer this new technology, which was approved in February 2011 by the federal Food and Drug Administration (FDA). The first woman to receive a digital tomosynthesis test in the region was processed at the hospital yesterday.

Digital breast tomosynthesis captures three-dimensional images of the breast versus the two-dimensional ones available through standard full-field . This gives a more comprehensive and clear image for the radiologist to interpret, increases the early detection rate for by up to 15%, and decreases the number of false positive findings by about 25%.

"Tomosynthesis gives doctors a clearer view of a woman's breast tissue and significantly helps us screen for and find potential breast cancers," explained Patricia Spencer, MD, chief of the Department of Diagnostic Imaging at & Infants.

The new technology is used at the same time the technologist conducts a routine digital mammography, which is still considered the "gold standard" in breast imaging. However, the two-dimensional digital mammography takes an image of the entire breast in one exposure, which means features of the breast can be hidden by overlapping tissue.

Tomosynthesis takes images from multiple angles and uses computer processing to compile them into a three-dimensional picture a radiologist can examine and manipulate. The added detail helps the radiologist pinpoint the size, location and shape of any breast abnormality, and can help distinguish real tumors from harmless abnormalities. Because digital breast tomosynthesis removes the layers of breast structure and tissue, it is particularly beneficial for women with dense breasts.

"The result is fewer calls to patients for further testing and less overall anxiety for women," Dr. Spencer said. Even though in 2010, the U.S. Preventive Services Task Force recommended screening every two years for women ages 50 to 74, the American Cancer Society still recommends annual screening for all women age 40 and older. Women & Infants adheres to the American Cancer Society recommendations, believing the best chance for survival and cure is . This is the hospital's motivation for bringing the advanced technology of digital tomosynthesis to the women of Rhode Island and southeastern New England.

Provided by Women & Infants Hospital

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Small cancer risk following CT scans in childhood and adolescence confirmed

The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...

Cancer created 8 hours ago | popularity not rated yet | comments 0

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Cancer created 9 hours ago | popularity not rated yet | comments 0

Novel RNA-based classification system for colorectal cancer

A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...

Cancer created 10 hours ago | popularity not rated yet | comments 0

Low radiation scans help identify cancer in earliest stages

A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Poliovirus vaccine trial shows early promise for recurrent glioblastoma

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

Cancer created 13 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.